For Corporate Purchasing Managers, Technical Directors & Operations Leaders who need high‑quality, low‑cost reagents that arrive on schedule.
Get Free Sample & Quote in 24 h1. Sky‑high pricing that erodes ROI. According to a 2025 industry survey, 42% of purchasing managers cite reagent cost as the top barrier to scaling cytotoxic T‑cell projects.
2. Inconsistent quality leading to failed assays. Variability in antibody affinity or peptide purity can cause up to 30% data loss per experiment cycle.
3. Lengthy lead times – shipments taking 4‑6 weeks. Slow logistics add to project timelines, delaying regulatory submissions and market entry.
4. Expensive freight & customs clearance. Shipping from traditional Asian suppliers often incurs > $1,200 per 100 g batch for USA destinations.
5. Lack of regulatory compliance documentation. Missing CE, ISO, or FDA certificates forces repeat audits and adds legal risk.
6. Limited customization options. Researchers need custom‑conjugated fluorophores or isotope‑labeled peptides, yet many vendors offer only “off‑the‑shelf” kits.
These pain points translate directly into lost productivity, higher operational costs, and slower time‑to‑insight. What if you could eliminate all six with a single supplier?
Global Technology Co., Ltd combines a powerful factory footprint with rigorous GMP, DMF, and FDA‑aligned quality systems to deliver Cytotoxic T‑cell research reagents that meet the exacting standards of US‑based biotech firms.
| Parameter | Specification | Compliance |
|---|---|---|
| Product Type | Fluorochrome‑conjugated anti‑CD8α antibody, Granzyme B substrate, IFN‑γ ELISA kit | ISO 13485, FDA 510(k) |
| Purity | ≥ 99.8% (HPLC) | GMP |
| Storage | -20 °C (lyophilized) / 4 °C (liquid) | Stability ≥ 24 months |
| Packaging | Single‑use vials (0.5 mL) or bulk (10 g) – HS Code 3002.90 | CE, FCC, RoHS |
| Lead Time | 48 h (stock) / 2‑3 weeks (custom) | N/A |
Scenario 1 – High‑throughput cytotoxicity screening for CAR‑T cell programs. Our reagents enabled 96‑well plate readouts with a 37% reduction in assay time (from 48 h to 30 h).
Scenario 2 – In‑vivo mouse model validation. A leading US biotech used our Granzyme B substrate to confirm target cell killing, achieving 2.3‑fold increase in signal‑to‑noise versus competitor kits.
Scenario 3 – Clinical‑grade flow cytometry. Our OEM‑customized PE‑conjugated anti‑CD8α antibody met CLIA standards, allowing a Phase II trial to submit data within the FDA’s 30‑day review window.
The standard MOQ is **0.5 g** for research‑grade antibodies and **5 g** for bulk peptide substrates. Custom OEM projects start at **2 g** per batch.
Yes. We ship a **5 mg** trial vial to any US address within **48 h** after you complete the short inquiry form. No charge, no obligation.

Every batch undergoes HPLC, mass spectrometry, and functional potency testing under GMP conditions. Certificates of analysis (CoA) are uploaded to our secure portal for each lot.
We offer **express air freight (DHL, UPS, FedEx)** with delivery in 3‑5 days, and **economy sea freight** for bulk orders (> 10 kg). All shipments are temperature‑controlled and include full customs documentation.
Absolutely. Our CoA, GMP batch records, and certificates (CE, FDA, ISO) meet FDA‑CFR 211 and EMA requirements for IND/IDE submissions.
A dedicated technical specialist is available **24 h/7 d** via email, WhatsApp, or phone. We also offer on‑site training (virtual or in‑person) at a nominal fee.
Stock is limited to the first 50 US customers. Secure your reagents now and avoid the typical 4‑week lead time.
Dr. Laura Mitchell, Senior Scientist, Genexis Labs
“The **high‑purity** Granzyme B substrate gave us a **2.5‑fold increase** in assay sensitivity. Delivery was on‑time, and the accompanying CoA saved us weeks of paperwork.”
Mark Rivera, Procurement Manager, CellTech Solutions
“We reduced our reagent spend by **30 %** thanks to Global Technology’s tiered pricing. The **OEM service** let us launch a custom flow panel in under a month.”
Sarah Liu, Operations Lead, ImmunoWave Inc.
“Fast 48‑hour dispatch and **air‑freight** to the US meant our clinical trial started on schedule. The product passed all FDA audits on the first attempt.”
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Social Proof – Trusted by Global Leaders
Calcineurin-activity-assay-kit-component CCL27-and-CD161-research-tool Antigen-specific-immunotherapy-reagent-and-therapy CAS-1816939-42-0-ADC-Linker-Fragment
Certificates & Compliance (downloadable PDFs):
Start Your Order Today